Immunological characteristics | Immune cells | Roles in CRLM |
---|---|---|
Immunosuppressive | Treg cells | Inhibit effective responses of effector T cells and contribute to immune evasion of CRC |
M2 macrophages | Secret cytokines including IL-10, TGF-β, CCL17 and CCL22 to induce the formation of an immunosuppressive TME; attenuate Th1 adaptive immunity; produce MMPs to regulate matrix remodelling | |
MDSCs | Induce the production of Treg cells and repress the function of effective NK cells; produce MMP-9 and VEGF to promote TME remodelling and angiogenesis | |
TANs | Recruit M2 macrophages and Treg cells to shape a suppressive TME in the liver; produce MMP-9 and neutrophil elastase to promote extravasation of CRC cells; form NETs to trap and facilitate the implantation of CRC cells to the liver; produce AGR2 to communicate with CRC cells to drive CRLM | |
Immuno-effective | CD4+ Th1 cells | Produce IFNγ and TNF-α, leading to cell-mediated killing |
CD4+ Th2 cells | Secrete IL-4, which assists in the activation of humoral immunity | |
CD8+ T cells | Secret cytotoxic granules and release proteins to kill disseminated CRC cells; produce TNF-α, IL-2 and IFNγ to strengthen the cytotoxicity | |
M1 macrophages | Kill cancer cells directly by releasing cytotoxic reactive oxygen species (ROS), NO and IL-12 | |
NKs | Release IFNγ and NO toupregulate the expression of functional Fas in CRC cells; exert cytotoxic effects to eliminate CRC cells by PRF and GZM and kill CRC cells directly by releasing the apoptosis-inducing ligand and FasL | |
DCs | Present antigens and deliver co-stimulatory signals for T-cell activation to initiate effective immune responses | |
TANs | Activate T-cell immune reaction by presenting antigens; release IL-18 to induce the activation of NK cells |